Rita Mancini

Pubblicazioni

Titolo Pubblicato in Anno
BDNF/TrkB axis activation promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis JOURNAL OF TRANSLATIONAL MEDICINE 2017
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells CANCER LETTERS 2017
Genetic polymorphism of CHRM2 in COPD. clinical significance and therapeutic implications JOURNAL OF CELLULAR PHYSIOLOGY 2016
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity JOURNAL OF TRANSLATIONAL MEDICINE 2016
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition ONCOTARGET 2016
miR-579-3p controls melanoma progression and resistance to target therapy PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2016
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression ONCOTARGET 2016
Inducers of epithelial mesenchymal transition and cancer stem cells in malignant pleural effusions HSOA JOURNAL OF CYTOLOGY & TISSUE BIOLOGY 2016
Review. cell dynamics in malignant pleural effusions JOURNAL OF CELLULAR PHYSIOLOGY 2015
Superior immunologic and therapeutic efficacy of a xenogeneic genetic cancer vaccine targeting carcinoembryonic human antigen HUMAN GENE THERAPY 2015
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children JOURNAL OF NEUROIMMUNOLOGY 2015
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma ONCOTARGET 2015
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer JOURNAL OF CELLULAR PHYSIOLOGY 2015
Rapid on-site evaluation (ROSE) in pancreatic cancer diagnosis. doing more with less ONCOCYTOLOGY 2015
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells ONCOTARGET 2015
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway FREE RADICAL BIOLOGY & MEDICINE 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma